Clinical Trials Browser

Phase 4 × OTHER × durvalumab × Clear all

NCT06031233 2025-05-21

MINUTE

Phase 4 Recruiting

Neoplasms

NCT04613284 2020-11-03

RELIEF

Phase 4 Unknown

Lung Neoplasms